CML
Clinical trials for CML explained in plain language.
Never miss a new study
Get alerted when new CML trials appear
Sign up with your email to follow new studies for CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for Hard-to-Treat CML
Disease control CompletedThis study looked at adding a new drug, asciminib, to the standard treatment imatinib for people with chronic myeloid leukemia (CML) who hadn't reached very low levels of cancer cells. 104 adults who had been on imatinib for at least a year were randomly assigned to add asciminib…
Matched conditions: CML
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
Healthy volunteers help calibrate new CML drug
Knowledge-focused CompletedThis study tested a new drug called IkT-001Pro in 64 healthy adults aged 18 to 55. The goal was to see how the body processes it compared to the standard cancer drug imatinib, and to check for side effects. Participants took single doses of each drug with a week in between. This …
Matched conditions: CML
Phase: PHASE1 • Sponsor: Inhibikase Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 10:57 UTC